Background/Aims: Tanshinone IIA is a chemical compound extracted from Salvia miltiorrhiza Bunge, a perennial plant also known as red sage used in traditional Chinese medicine. Tanshinone IIA has been shown to protect against various organ injuries. In this study, we hypothesized that Tanshinone IIA could play an anti-oxidative role in contrast-induced nephropathy (CIN) through enhancing Nrf2/ARE activation. Methods: To test whether Tanshinone IIA can attenuate CIN, oxidative stress, and apoptosis, we utilized two models: an in vivo Sprague-Dawley rat model of ioversol-induced CIN and an in vitro cell model of oxidative stress in which HK2 cells, a human renal tubular cell line, are treated with hydrogen peroxide (H 2 O 2 ). Rats were randomly assigned to 4 groups (n = 6 per group): control group, ioversol group (ioversol-induced CIN), vehicle group (ioversol-induced CIN rats pretreated with vehicle), and Tanshinone IIA group (ioversol-induced CIN rats pretreated with 25mg/kg Tanshinone IIA). Renal functions, renal injuries and apoptosis were evaluated by using serum creatinine, histological scoring, and TUNEL staning respectively. Malondialdehyde, 8-hydroxy-2' -deoxyguanosine, and intracellular reactive oxygen species were used for oxidative stress assessment. Levels of Nrf2 and heme oxygenase-1 (HO-1) were measured in vivo and in vitro. Results: Tanshinone IIA attenuated renal tubular necrosis, apoptosis and oxidative stress in rats and oxidative stress in HK2 cells. Furthermore, Tanshinone IIA activated Nrf2, and up-regulated HO-1 expression in vivo and in vitro, resulting in a reduction in oxidative stress. Conclusion: Tanshinone IIA may protect against CIN through enhancing Nrf2/ARE activation.
Introduction
The use of contrast media is becoming more and more common in radiology diagnosis [1] . Contrast-induced nephropathy (CIN) is a frequent complication. The incidence of CIN varies from 3% to 14% and can reach as high as 20% in patients with high risk [2, 3] . Recent evidence suggests that CIN can cause long-term decline in renal function, leading to increased mortality [4, 5] . These detrimental effects demonstrate the necessity for the development of new preventive strategies for CIN.
A variety of molecules contained in the roots of the perennial plant Salvia miltiorrhiza Bunge can be extracted [6, 7] . Some of these molecules have been widely applied in traditional Chinese medicine, especially in the treatment of cardiovascular and cerebrovascular diseases. Tanshinone IIA is an active monomer extracted from S. miltiorrhiza [8] , which plays a key role in the plant's clinical efficacy. Previous studies suggest that Tanshinone IIA is neuroprotective in cerebral ischemia reperfusion injury [8, 9] and renoprotective in renal ischemia reperfusion injury [10] .. However, the effects of Tanshinone IIA in CIN have not been investigated.
The mechanism of action for Tanshinone IIA remains unknown. Previous studies suggest that Tanshinone IIA may regulate proteins involved in apoptosis or necrosis, including B-cell lymphoma-2 (Bcl-2), Bcl-2-associated X protein (Bax), Transient receptor potential cation channel subfamily M member 7 (TRPM7), and the PI3K/AKT signaling pathway [11] . Additionally, Tanshinone IIA has been shown to have anti-oxidative properties in hepatic cell injury [12] .
Nuclear factor erythroid 2 (Nrf2) is a pleiotropic transcription factor that plays a crucial role in maintaining homeostasis during intracellular and extracellular stress, by helping cells adapt to detrimental conditions [13] . Once Nrf2 is activated, it enters the nucleus and binds to antioxidant response elements (AREs), inducing transcription of a large number of antioxidant genes including heme oxygenase-1 (HO-1) [14] . A recent study showed that Nrf2 activation contributes to the neuroprotective effects of Tanshinone IIA during ischemic stroke through its anti-oxidative properties [15] . In the present study, we observed the effects of Tanshinone IIA preteatment on CIN induction, and investigated the underlying mechanism, which we proposed occurred through the Nrf2/ARE pathway.
Materials and Methods

Reagents and Animals
The Tanshinone IIA reagents were provided by Jiangsu Carefree Group Co. (Nanjing, China). Tanshinone IIA was solubilized in saline with 0.02% DMSO for administration. Male Sprague-Dawley rats from Shanghai Science Academy animal center, weighing 200 ± 20 g, were housed in individual cages under controlled conditions for light (12 h dark/12 h light cycle) and temperature (20) (21) (22) (23) ∘ C). All rats were provided standard diet and tap water ad libitum.
Animal study and group assign
The animal experiments were approved by the Animal Care and Ethics Committee of Shanghai Jiao Tong University Affiliated Sixth People's Hospital. The CIN rat model was conducted as previously described [16] . The rats were divided into control group (Ctl) (n = 6), ioversol group (Iov) (n = 6), vehicle group (Veh) (n = 6), and Tanshinone IIA group (Tan) (n = 6). Rats in the Iov, Veh, and Tan groups were anesthetized with 50mg/kg pentobarbital and given a tail vein injection of indomethacin (Sigma, USA) (10mg/kg), followed by ioversol (Hengrui Corp., China) (3g/kg organically bound iodine). Rats in the Ctl group received injections of saline alone at each time point. Rats in the Tan group received a subcutaneous injection of Tanshinone IIA (25mg/kg) 15 minutes prior to the CIN inducing injections. Rats in the Veh group received a subcutaneous injection of vehicle (saline with 0.02% DMSO) (25mg/kg) 15 minutes prior to the CIN inducing injections. The rats recovered in metabolic cages for 24 hours for urine collection. After 24 hours, the left kidneys were harvested for associated measurements. The right kidneys were fixed in 10% formalin for histological assessments. Blood was collected to isolate serum and then stored in a −80 ∘ C freezer.
Renal function
Serum creatinine was measured using a colorimetric microplate assay based on the Jaffe reaction (BioAssay Systems, Hayward, CA, USA). A colorimetric assay kit was used to quantify the levels of blood urea nitrogen (BUN) in accordance with the manufacturer's protocol (BioAssay Systems).
Histological examinations
Right kidneys were fixed in 10% formalin, then dehydrated in ethanol and embedded in paraffin. Kidney tissue blocks were cut into 4 μm sections and subjected to Periodic Acid Schiff (PAS) staining. The sections were viewed by light microscopy. The histological scoring was assessed by the following criteria for the presence of acute necrosis in proximal tubular cells: 0, none; 1, 0-10%; 2, 11-25%; 3, 26-45%; 4, 46-75% and 5, 76-100%, as described previously [17] . For each animal, three renal tissue sections were selected and 10 random microscopic fields at 400X magnification in each slide were selected for scoring. Two independent pathologists were blinded to the experimental conditions, and evaluated the presence of acute necrosis in proximal tubular cells according to the scoring criteria. Renal cell apoptosis was assessed using TUNEL staining (Roche Diagnostics, Mannheim, Germany) as described previously [18] .
Examination of Lipid Peroxide
Malondialdehyde (MDA), a product of reduction in the lipid peroxidation processes [19] , was detected using a commercial kit (Nanjing Jiancheng, Jiangsu, China) for supernatant of the renal cortical homogenate, according to the manufacturer's instruction.
ELISA assay
Serum neutrophil gelatinase-associated lipocalin (sNAGL) and urinary kidney injury molecule-1 (uKIM-1) were measured using commercial ELISA kits (R&D, USA). The concentration of 8-hydroxy-2' -deoxyguanosine (8-OHdG) was also assessed by commercial ELISA kits (Japan Institute for the Control of Aging, Shizuoka, Japan).
ROS assay for HK2
HK2 cells (ATCC, Manassas, USA) were cultured in K-SFM at 37 ∘ C 5% CO2, supplemented with 5 ng/ mL human recombinant Epidermal growth factor (EGF) and 0.05 mg/mL bovine pituitary extract. HK2 cells were preconditioned with Tanshinone IIA (40 µg/mL) for 1h at 37 o C. Then the cells were washed 3 times by PBS followed by 500 µmol/L H 2 O 2 incubation for 5 min at room temperature to induce oxidative stress injury. Intracellular reactive oxygen species (ROS) was measured with commercial kits (Cell Biolabs, San Diego, USA) using Dichloro-dihydro-fluorescein diacetate (DCFH-DA) method. Briefly, cells were harvested and washed three times with PBS, and stained with 10 mM DCFH-DA in serum-free cell culture medium at 37 ∘ C for 30 min, with inversion every 5 min. The cells were then washed three times with serum-free medium, and the fluorescent product DCF was measured using a spectrofluorimeter with excitation at 484 nm and emission at 530 nm [20] .
Western blot
Western blot was conducted following previously described methods [5] . The primary antibodies were rabbit antibodies to Nrf2 (dilution 1:200, Santa Cruz, USA) or HO-1 (dilution 1:1000, Santa Cruz, USA). Antibodies to histone H3 (dilution 1:500, Cell Signaling Technology, USA) or GAPDH (dilution 1:500, Santa Cruz, USA) were used as internal controls for the nuclear and cytosolic target proteins, respectively. Each membrane was incubated for 1-2 hours with a secondary antibody conjugated by peroxidase (1:200, Zhongshanjinqiao Biotech., China) at room temperature, detected by ECL regent (Millipore, US).
HO-1 activity assay and ARE reporter assay
HO-1 activity was determined with a commercial assay kit (Nanjing Jiancheng, Jiangsu, China). ARE reporter assay was used to confirm the transcriptional activity of Nrf2 on HK2 using a SignalTM ARE Reporter Assay Kit (SABiosciences, USA). The assay was carried out according to the manufacturer's instruction. 
Statistical analysis
All the data were expressed as mean±SE. Statistical analysis was performed using SPSS software (Ver. 18.0, Chicago, IL, USA). Statistical significance was assessed by one-way analysis of variance (ANOVA). A value of P<0.05 was considered to be statistically significant.
Results
Tanshinone IIA pretreatment alleviated renal injury
To evaluate the severity of tubular injury, PAS staining was performed. Tubular detachment, foamy degeneration, and necrosis were seen in kidney sections from rats with ioversol-induced CIN treatment (Fig. 1A) . The morphological damage and tubular scores in Veh and Iov groups were much more severe than the Tan group. Serum creatinine and blood urea nitrogen also increased significantly in rats with ioversol-induced CIN treatment. However, serum creatinine and blood urea nitrogen in the rats of Tan group were significantly lower than the Veh and Iov groups (Fig. 1B and 1C) .
Tanshinone IIA mitigated renal apoptosis
The TUNEL assay showed that apoptotic cell number increased with ioversol-induced CIN treatment, but the effect was significantly attenuated in the Tan group (Fig. 2A) . To evaluated kidney cell injury, sNGAL and uKIM-1 were measured with ELISA assay [21] . In CIN rats, both uKIM-1 and sNGAL levels increased significantly while they were reduced in the Tan group (Fig. 2B and 2C ).
Tanshinone IIA enhanced Nrf2 activation and alleviated renal oxidative stress
Renal MDA and 8-OHdg levels increased in rats with ioversol treatment. With Tanshinone IIA pretreatment, renal MDA and 8-OHdg were alleviated (Fig. 3A and 3B) . To explore the mechanism of anti-oxidation, we evaluated Nrf2 activation in the nucleus and found it was enhanced in Tan group (Fig. 3C) . Moreover, renal HO-1 expression, the downstream gene of Nrf2, was up-regulated in the Tan group compared to the Veh and Iov groups Fig. 3D . ( )
Tanshinone IIA reduced oxidative stress and enhanced Nrf2 activation in vitro
An oxidative injury model with HK2 cells was used to investigate the influence of Tanshinone IIA on Nrf2, (Fig. 4) . ROS levels increased 24h following H 2 O 2 treatment, while Tanshinone IIA reduced ROS levels (Fig. 4A) . Moreover, Tanshinone IIA increased activated Nrf2 expression and ARE activity as well as upregulated HO-1 (Fig. 4B,  4D and 4E) . Additionally, HO-1 activity in H 2 O 2 treated HK2 cells was elevated, but there was no significant difference between the H 2 O 2 group and Tanshinone IIA group (Fig. 4C) .
Discussion
In the present study, we observed that Tanshinone IIA pretreatment protected against renal tubular injury and improved renal function in a rat CIN model. Meanwhile, cell apoptosis, uKIM-1 and sNGAL levels were reduced. Tanshinone IIA decreased oxidative stress in injured kidney tissues and HK2 cells under oxidative condition.
Nrf2/ARE enhancement and HO-1 up-regulation were observed with Tanshinone IIA pretreatment both in vivo and in vitro. However, Tanshinone IIA did not change HO-1 activity in vitro.
CIN is a very common iatrogenic acute kidney injury [22] [23] [24] [25] [26] . There are many circumstances in which it is medically necessary to utilize contrast-enhanced imaging, despite the significant risk of CIN. Oxidative stress and inflammation play an important role in the pathogenesis of many kidney injuries including CIN [27] [28] [29] [30] . Contrast media induces ROS that causes lipid peroxidation and inflammation. Development or identification of new drugs that can scavenge ROS has been a major focus for the prevention of CIN in high-risk patients [31] .
In traditional Chinese medicine, natural herbs and plants are used to treat numerous diseases. Many molecules extracted from plants have therapeutic value and are commonly used in the treatment of human diseases. For instance, artemisinin from Artemisia annua L. is widely used to treat malaria [32] . Tanshinone IIA is a key active monomer extracted from S. miltiorrhiza [8] and has been used to treat cardiovascular and cerebrovascular diseases. In this study, Tanshinone IIA preconditioned rats with CIN exhibited lower levels of oxidative stress. The results were consistent with previous studies which focused on Tanshinone IIA for neurologic injury [15] . In the present study, we demonstrated that Tanshinone IIA has protective effects on CIN, and that these protective effects are related, at least in part, to its anti-oxidative properties. The anti-oxidative molecular mechanism of Tanshinone IIA is still unclear. A recent study reported that Tanshinone IIA could up-regulate the expression of Bcl-2, an anti-apoptotic protein [10] . On another hand, it was also reported Nrf2 activation contributed to Tanshinone IIA induced neuroprotection by inducing transcription of large numbers of antioxidant genes including heme oxygenase-1 (HO-1) [15] . We hypothesized that Tanshinone IIA might play the same role in preventing CIN. Thus, we performed Nrf2 expression assay and found that Nrf2/ARE pathway was activated by Tanshinone IIA pretreatment both in vivo and in vitro in the present study. Furthermore, HO-1, which is the ARE-regulated antioxidant enzyme, was also up-regulated by Tanshinone IIA. There was no significant difference of HO-1 activity between the H 2 O 2 group and Tanshinone IIA pretreatment group in vitro, suggesting that the anti-oxidative effects of Tanshinone IIA only depend on Nrf2 induced HO-1 upregulation, but not on HO-1 activity change.
Under non-stressful conditions, Nrf2 is maintained at low levels due to rapid degradation via Keap1-dependent ubiquitin conjugation [33, 34] . When stress increases, Nrf2 is activated and exerts anti-oxidative effects. We deduced that Tanshinone IIA pretreatment could enhance Nrf2/ARE activation and play a renoprotective role. Another mechanism for Nrf2 activation may be through the MAP kinase or PI3-k/Akt pathways [35] . A previous study suggested that in human aortic smooth muscle cells, Tanshinone IIA-induced Nrf2 activation was associated with activation of ERK and PKB [36] . Further investigation is needed to elucidate the detailed molecular mechanisms involved in the protective effects of Tanshinone IIA on CIN.
Conclusion
This study suggested that Tanshinone IIA exhibits renal protection in CIN models through antioxidative and antiapoptotic pathways. Nrf2/ARE activation might be one of the underlying mechanisms of Tanshinone IIA. Tanshinone IIA could be a novel antioxidant to CIN therapy in the future. 
